| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |